HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The relation between fibrinogen level, neutrophil activity and nucleosomes in the onset of disseminated intravascular coagulation in the critically ill.

AbstractBACKGROUND:
Nucleosomes and neutrophil extracellular traps (NETs) are important in the pathophysiology of disseminated intravascular coagulation (DIC). Fibrinogen, as an acute phase reactant, may be protective by engaging neutrophils. We hypothesize that DIC can occur when NET formation becomes uncontrolled in relation to low fibrinogen levels.
PATIENTS/METHOD:
The ratio of both circulating nucleosomes and human neutrophil elastase alpha-1-antitrypsine complexes (HNE-a1ATc) to fibrinogen was correlated to thrombocytopenia, DIC and organ failure in 64 critically ill coagulopathic patients.
RESULTS:
A high nucleosome to fibrinogen ratio correlated with thrombocytopenia and organ failure (ρ -0.391, p 0.01 and ρ 0.556, p 0.01, respectively). A high HNE-a1ATc to fibrinogen ratio correlated with thrombocytopenia, DIC and organ failure (ρ -0.418, p 0.01, ρ 0.391, p 0.01 and ρ 0.477, p 0.01 respectively).
CONCLUSION:
These findings support the hypothesis that fibrinogen is protective against DIC by counterbalancing excessive neutrophil activation.
AuthorsMarcella C A Müller, Romein W G Dujardin, Jecko Thachil, Gerard van Mierlo, Sacha S Zeerleder, Nicole P Juffermans
JournalJournal of internal medicine (J Intern Med) Vol. 290 Issue 4 Pg. 922-927 (10 2021) ISSN: 1365-2796 [Electronic] England
PMID34137469 (Publication Type: Journal Article)
Copyright© 2021 The Association for the Publication of the Journal of Internal Medicine.
Chemical References
  • Nucleosomes
  • Fibrinogen
Topics
  • Critical Illness
  • Disseminated Intravascular Coagulation (diagnosis)
  • Fibrinogen (analysis)
  • Humans
  • Neutrophils (cytology)
  • Nucleosomes
  • Thrombocytopenia

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: